This growth opportunity-technology (GO-TE) study identifies and analyzes some of the key developments in diagnostic medical devices across major therapeutic areas such as cardiology, neurology, and oncology. The research highlights the breakthrough diagnostic medical device technologies that are likely to be approved in the next 2-3 years. These promising technologies are set to make a significant impact in near future. Innovations such as sensor technology, lab-on-a-chip, artificial intelligence (AI)-based software, imaging technology, and novel biomarker-based diagnosis are in late stage clinical trials. This report analyzes these innovative technologies and their unique value propositions. The report identifies key growth opportunities of technologies, strategic imperatives, and market expansion strategies for medtech companies in this space.